Herpes viruses

2010 ◽  
pp. 35-58
Author(s):  
Eleftherios C. Vamvakas ◽  
Gary E. Tegtmeier
Keyword(s):  
2020 ◽  
Vol 62 ◽  
pp. 106-122 ◽  
Author(s):  
Emmanuelle Jouanguy ◽  
Vivien Béziat ◽  
Trine H Mogensen ◽  
Jean-Laurent Casanova ◽  
Stuart G Tangye ◽  
...  

2010 ◽  
Vol 93 (6) ◽  
pp. 1778-1786 ◽  
Author(s):  
Peter Oppelt ◽  
Stefan P. Renner ◽  
Reiner Strick ◽  
Daniela Valletta ◽  
Grit Mehlhorn ◽  
...  

1985 ◽  
Vol 5 ◽  
pp. 21-28 ◽  
Author(s):  
Brigitte Rosenwirth ◽  
Herfried Griengl ◽  
Erich Wanek ◽  
Erik de Clercq

1924 ◽  
Vol 39 (4) ◽  
pp. 533-542 ◽  
Author(s):  
James E. McCartney

These studies fail to confirm the statements previously made that microorganisms of the class of the globoid bodies of poliomyelitis may be cultivated in the Smith-Noguchi medium from the so called virus of encephalitis lethargica. They show equally that the herpes virus does not multiply in this medium. The experiments indicate, moreover, that the medium is unfavorable to the survival of the virus, while ordinary broth under aerobic conditions is more favorable for maintaining the activity of both the encephalitic and the herpes viruses. Probably no multiplication of either takes place in the latter medium but merely a survival, and for a maximum period of 6 days in the broth itself, and 12 days in the fragment of brain tissue immersed in the broth. Finally, it has been shown that with a suitable technique the viruses can be passed from the brain of one rabbit to that of another through a long series without contamination with cocci or other common bacterial forms. Hence we regard all reports of the finding of ordinary bacteria in the brain of cases of epidemic or lethargic encephalitis as instances of mixed or secondary infection arising during life, or examples of postmortem invasion of the body, or of faulty technique at the autopsy.


2007 ◽  
Vol 34 (6) ◽  
pp. 1182-1188 ◽  
Author(s):  
David W. Niebuhr ◽  
Amy M. Millikan ◽  
Robert Yolken ◽  
Yuanzhang Li ◽  
Natalya S. Weber

Abstract Background: Herpes family viruses can cause central nervous system inflammatory changes that can present with symptoms indistinguishable from schizophrenia and therefore are of interest in schizophrenia research. Most existing studies of herpes viruses have used small populations and postdiagnosis specimens. As part of a larger research program, we conducted a hypothesis-generating case-control study of selected herpes virus antibodies among individuals discharged from the US military with schizophrenia and pre- and postdiagnosis sera. Methods: Cases (n = 180) were servicemembers hospitalized and discharged from military service with schizophrenia. Controls, 3:1 matched on several factors, were members not discharged. The military routinely collects and stores members' serum specimens. We used microplate enzyme immunoassay to measure immunoglobulin G (IgG) antibody levels to 6 herpes viruses in pre- and postdiagnosis specimens. Conditional logistic regression was used, and the measure of association was the hazard ratio (HR). Results: Overall, we found a significant association between human herpes virus type 6 and schizophrenia, with an HR of 1.17 (95% confidence interval [CI] = 1.04, 1.32). Women and blacks had significant negative associations with herpes simplex virus type 2 and cytomegalovirus; among blacks, there was a significant positive association with herpes simplex virus type 1. Among men, there was a HHV-6 temporal effect with an HR of 1.41 (95% CI = 1.02, 1.96) for sera drawn 6–12 months before diagnosis. Discussion: Findings from previous studies of herpes family viruses and schizophrenia have been inconsistent. Our study is based on a larger population than most previous studies and used serum specimens collected before onset of illness. This study adds to the body of knowledge and provides testable hypotheses for follow-on studies.


1992 ◽  
Vol 30 (26) ◽  
pp. 101-104 ◽  

Acyclovir (Zovirax; Wellcome) is now widely prescribed for the treatment of herpes infections. In 1984 we hailed acyclovir as an important advance for the “early treatment of primary skin and ocular herpes simplex infections and for varicella-zoster infections requiring systemic treatment”, but warned against using it “indiscriminately in view of the cost, the lack of data on toxicity and the increasing number of acyclovir-resistant herpes viruses being reported.”1 In this article we appraise the place of acyclovir in general practice and so for the treatment of patients likely to be immunocompetent and without severe systemic infection.


Infection ◽  
2012 ◽  
Vol 41 (1) ◽  
pp. 27-31 ◽  
Author(s):  
L. A. Benjamin ◽  
M. Kelly ◽  
D. Cohen ◽  
F. Neuhann ◽  
S. Galbraith ◽  
...  

2010 ◽  
Vol 9 (3) ◽  
pp. 234-236 ◽  
Author(s):  
Simone Scheithauer ◽  
Gerhard Haase ◽  
Martin Häusler ◽  
Sebastian Lemmen ◽  
Klaus Ritter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document